Skip to main content
LBRX
NASDAQ Life Sciences

Q3 Loss of $1.79 a Share Misses Consensus as R&D Spending Climbs

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$38.09
Mkt Cap
$1.229B
52W Low
$14.317
52W High
$50.16
52W Position info
166% above low
Off High info
24% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LBRX has more than doubled off its 52-week low of $14.317.

Summary

LB Pharmaceuticals posted a Q3 adjusted loss of $1.79 per share, wider than the $1.62 consensus and well past the 61-cent loss a year earlier. The net loss came to $59.07 million, driven by Phase 3 R&D spending, and revenue was zero as expected for a clinical-stage biotech. Cash stood at $403.8 million at quarter-end, which management says funds operations past Q2 2029 — the balance sheet, not the P&L, is what matters here. This is the second straight quarter of a wider-than-expected loss after Q2's $1.71 versus $0.80 expected, and analysts have cut their mean estimate about 76% over three months. The stock is up 83.5% year to date and 6.4% this quarter, so the miss lands against a strong run; the $200M ATM shelf filed October 1st remains the dilution overhang to track.

At the time of this announcement, LBRX was trading at $38.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $14.32 to $50.16. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LBRX - Latest Insights

LBRX
Nov 05, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $38.09
Real-time Price: $41.00 info
Change: +$2.91 (+8%) info
Market Cap: $1.296B info
LBRX
Nov 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.09
Real-time Price: $41.00 info
Change: +$2.91 (+8%) info
Market Cap: $1.296B info
LBRX
Oct 01, 2026, 4:05 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $37.28
Real-time Price: $41.00 info
Change: +$3.72 (+10%) info
Market Cap: $1.296B info
LBRX
Aug 11, 2026, 8:10 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $46.76
Real-time Price: $41.00 info
Change: -$5.76 (-12%) info
Market Cap: $1.296B info
LBRX
Aug 11, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $46.76
Real-time Price: $41.00 info
Change: -$5.76 (-12%) info
Market Cap: $1.296B info